NCT04802759 2026-03-16A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerHoffmann-La RochePhase 1/2 Recruiting316 enrolled
NCT07100106 2026-03-12A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerGenentech, Inc.Phase 1/2 Recruiting285 enrolled